MY
Myomo, Inc.
MYO · AMEX
$1.43 +2.14% (+$0.03)
1M +0.70%
Market Cap $55.3M
P/E Ratio -
Div. Yield -
ROE 142.02%
Bulios Fair Price
$0.73
49.0% downside
Current Price
$1.43
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MYO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
49 /100
Fair P/S 1.28x
P/B 9.48x
P/E N/A
Growth
100 /100
Growing Rev. growth 38.05%
Book val. growth 21.49%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 68.35%
Net margin 33.53%
Op. margin 27.05%
Quality
15 /100
Poor ROIC 46.57%
ROE 142.02%
ROA 41.05%
Debt
23 /100
High Debt/Equity 3.44x
Current ratio 2.31x
Int. coverage -6.86x
Stability
22 /100
Unstable Beta 1.50x
Rev. volatility 25.69%
EPS volatility 113.36%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MYO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Paul R. Gudonis
Employees
195
Headquarters
Burlington
Upcoming events
09 NOV
Earnings
Upcoming earnings report